Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

The Viz.AI pulmonary embolism response team (PERT) app that uses AI to detect PE on images before they go into PACS, alerts the PERT team members and provides a mobile platform to message, review images and other patient data. Photo by Dave Fornell
Feature | Artificial Intelligence | By Dave Fornell, DAIC Editor

Artificial intelligence (AI) has found a unique niche to help automate the activation of acute care teams for pulmonary ...

Home December 09, 2021
Home
News | Coronavirus (COVID-19)

December 7, 2021 – Critically ill patients with COVID-19 can safely be transported for lifesaving extracorporeal ...

Home December 07, 2021
Home
News | ACC

December 7, 2021 — The American College of Cardiology (ACC) has named Ami B. Bhatt, M.D., FACC, as chief innovation ...

Home December 07, 2021
Home
Videos | Cardiovascular Ultrasound

Examples of TrueView and GlassView 3D cardiac ultrasound visualization and artificial intelligence (AI) assisted ...

Home November 24, 2021
Home
Videos | EP Lab

Christine Albert, M.D., MPH, professor, chair of the Department of Cardiology and the Lee and Harold Kapelovitz ...

Home November 22, 2021
Home
News | Heart Failure

November 19, 2021 — Adults treated with empagliflozin during hospitalization for acute heart failure experienced a ...

Home November 19, 2021
Home
News | Stem Cell Therapies

November 19, 2021 — Stem cell therapy helped to reduce the number of heart attacks, strokes and death among people with ...

Home November 19, 2021
Home
News | Cardiovascular Surgery

November 18, 2021 — Moderna Inc. announced positive data from the AstraZeneca-led Phase 2 (EPICCURE) study evaluating ...

Home November 18, 2021
Home
News | Structural Heart

November 18, 2021 — Adults undergoing mitral valve surgery who have less than severe leakage of the tricuspid valve may ...

Home November 18, 2021
Home
News | Hypertension

November 18, 2021 — Village doctors who were community health workers in rural China were trained and successfully ...

Home November 18, 2021
Home
News | Heart Failure

November 17, 2021 — Canagliflozin, a medication used to treat type 2 diabetes, was found to greatly improve symptoms and ...

Home November 17, 2021
Home
News | Structural Heart

November 17, 2021 — For people experiencing severe aortic stenosis who do not have symptoms or need symptom relief ...

Home November 17, 2021
Home
Videos | Cardiogenic Shock

Srihari Naidu, M.D., FACC, FAHA, FSCAI, is the director of both the cardiac cath labs and Hypertrophic Cardiomyopathy ...

Home November 16, 2021
Home
Subscribe Now